Megan Doyle

Digital Health

Global Regulatory and R&D Policy Lead


and Combination Products


Megan Doyle is an attorney with more than 1 years advising on matters pertaining to the regulation of drugs, medical devices, combination products, and in vitro diagnostics. She received her law degree from Georgetown University Law Center and her master’s in public health from Johns Hopkins University. After seven years in the medical device practice at Hogan Lovells, she joined Amgen as a Senior Counsel for Health Regulatory. For four years, she counseled Amgen on drug, device, combination product, and diagnostic matters. In particular, she advised product teams developing new, innovative delivery devices and digital health solutions. She also served as the law department companion diagnostic lead, advising on the co-development process for teams developing targeted therapies that require a companion diagnostic. Currently, she is a Director in Amgen’s Global Regulatory and R&D Policy group, where she is the Global Policy Lead for Diagnostics, Digital Health, and Combination Products.